Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Altaf Mohammed
Based on 21 articles published since 2010
(Why 21 articles?)
||||
Expertise Level
The expertise of Altaf Mohammed ranks in the
  • Top 0.5%
  • ... of 100,606 published authors worldwide on Pancreatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Mohammed, A   ·   Mohammed, Altaf
Work Locations
Details
Most likely:    National Institutes of Health      
2019
  • Division of Cancer Prevention, Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, Maryland. · Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, VA Medical Center, Oklahoma City, Oklahoma. · Pubmed 31313401
2018
  • Chemopreventive Agent Development Research Group (CADRG) Division of Cancer Prevention National Cancer Institute Rockville, MD 20850, United States. · Center for Cancer Prevention and Drug Development (CCPDD) Stephenson Cancer Center, Medical Oncology University of Oklahoma Health Sciences Center Oklahoma City, OK 73104, United States. · Pubmed 30014794
2017
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Current address: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · VA Medical Center, Oklahoma City, OK, USA. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Pubmed 29228654
Probable:    University of Oklahoma      
2018
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. · Pubmed 28240168
  • Department of Medicine, Hem-Onc Section, Center for Cancer Prevention and Drug Development, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. · Pubmed 28183260
2017
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Current address: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · VA Medical Center, Oklahoma City, OK, USA. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Pubmed 29228654
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Pubmed 28419443
2016
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Pubmed 26880801
2015
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 26266422
  • Chinthalapally V Rao, Altaf Mohammed, Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States. · Pubmed 25914762
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, MD, USA. · Pubmed 26429877
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Digestive Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Division of Cancer Prevention, Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, MD, USA. · Pubmed 25906749
2014
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, Maryland. · Pubmed 25248858
2012
  • Center for Cancer Prevention and Drug Development, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 23308056
  • Center for Chemoprevention and Cancer Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Pubmed 22287227
2010
  • Center for Chemoprevention and Drug Development, Department of Medicine, Hematology-Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. · Pubmed 21084261
2013
  • Department of Biochemistry and Molecular Biology, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Pubmed 23712558
2012
  • Center for Chemoprevention and Cancer Drug Development, 975 NE 10th Street, BRC 1205, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 22680926
  • Hematology/Oncology Section, Center for Cancer Prevention and Drug Development, Peggy and Charles Stephenson Cancer Center, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 23019409
2011
  • Center for Chemoprevention and Cancer Drug Development, Department of Medicine, Medical Oncology, PC Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1203, Oklahoma City, OK 73104, USA. · Pubmed 22015691
  • Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. · Pubmed 21285251
Probable:    Miscellaneous institutions in Oklahoma City      
2012
  • Center for Chemoprevention and Cancer Drug Development, PCS Oklahoma Cancer Center, 975 NE 10th Street, BRC 1203, OUHSC, Oklahoma City, OK 73104, USA. · Pubmed 22680929
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Altaf Mohammed about Pancreatic Neoplasms:

  • Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. 2019
  • Pancreatic Cancer Chemoprevention: Challenges and Opportunities. 2018
  • Immunoprevention of Pancreatic Cancer. 2018
  • Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. 2018
  • Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. 2017
  • Loss of natural killer T cells promotes pancreatic cancer in LSL-Kras 2017
  • Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. 2016
  • Molecular Targeted Intervention for Pancreatic Cancer. 2015
  • New insights into pancreatic cancer stem cells. 2015
  • Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma. 2015
Show List of Full Article Records
Google Searches

Learn more about Altaf Mohammed using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
University of Oklahoma
Miscellaneous institutions in Oklahoma City
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2019
  • Division of Cancer Prevention, Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, Maryland. · Center for Cancer Prevention and Drug Development, Hem-Onc Section, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, VA Medical Center, Oklahoma City, Oklahoma. · Pubmed 31313401
2018
  • Chemopreventive Agent Development Research Group (CADRG) Division of Cancer Prevention National Cancer Institute Rockville, MD 20850, United States. · Center for Cancer Prevention and Drug Development (CCPDD) Stephenson Cancer Center, Medical Oncology University of Oklahoma Health Sciences Center Oklahoma City, OK 73104, United States. · Pubmed 30014794
2017
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Current address: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · VA Medical Center, Oklahoma City, OK, USA. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Pubmed 29228654
University of Oklahoma
2018
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. · Pubmed 28240168
  • Department of Medicine, Hem-Onc Section, Center for Cancer Prevention and Drug Development, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. · Pubmed 28183260
2017
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Current address: Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · VA Medical Center, Oklahoma City, OK, USA. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. · Pubmed 29228654
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology Oncology Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Pubmed 28419443
2016
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Pubmed 26880801
2015
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 26266422
  • Chinthalapally V Rao, Altaf Mohammed, Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology-Oncology Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States. · Pubmed 25914762
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, MD, USA. · Pubmed 26429877
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Department of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Digestive Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Division of Cancer Prevention, Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, MD, USA. · Pubmed 25906749
2014
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, Maryland. · Pubmed 25248858
2012
  • Center for Cancer Prevention and Drug Development, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 23308056
  • Center for Chemoprevention and Cancer Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. · Pubmed 22287227
2010
  • Center for Chemoprevention and Drug Development, Department of Medicine, Hematology-Oncology Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. · Pubmed 21084261
2013
  • Department of Biochemistry and Molecular Biology, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Pubmed 23712558
2012
  • Center for Chemoprevention and Cancer Drug Development, 975 NE 10th Street, BRC 1205, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 22680926
  • Hematology/Oncology Section, Center for Cancer Prevention and Drug Development, Peggy and Charles Stephenson Cancer Center, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. · Pubmed 23019409
2011
  • Center for Chemoprevention and Cancer Drug Development, Department of Medicine, Medical Oncology, PC Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1203, Oklahoma City, OK 73104, USA. · Pubmed 22015691
  • Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. · Pubmed 21285251
Miscellaneous institutions in Oklahoma City
2012
  • Center for Chemoprevention and Cancer Drug Development, PCS Oklahoma Cancer Center, 975 NE 10th Street, BRC 1203, OUHSC, Oklahoma City, OK 73104, USA. · Pubmed 22680929
Yearly article counts 01321411521
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.